Endometrial Adenocarcinoma: Beliefs and Scepticism

International Journal of Surgical Pathology

Volumn 12, Issue 2, 2004, Pages 99-105

  Sivridis, Efthimios ^a   Giatromanolaki, Alexandra ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Adenocarcinoma; Classification; Differentiation; Endometrium; Estrogen dependence; Postmenopausal activity

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; TAMOXIFEN;

BREAST CARCINOMA; CANCER INCIDENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CLEAR CELL CARCINOMA; DENSITY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM ATROPHY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HEREDITY; HORMONAL REGULATION; HUMAN; MICROVASCULATURE; PAPILLARY CARCINOMA; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; REPRODUCIBILITY; REVIEW; TAXONOMY;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; POSTMENOPAUSE; PROGNOSIS;

EID: 2142810166     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690401200202     Document Type: Review

References (62)

1. Tkeshelashvili VT, Bokhman JV, Kuznetzov VV, Maximov SJ, Chkuaseli GT. Geographic peculiarities of endometrial and cervical cancer incidence in five continents. Eur J Gynaecol Oncol 14:89-94, 1993
2. Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: Review of the evidence and research perspectives. Ann N Y Acad Sci 943:296-315, 2001
3. Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293:1164-1167, 1975
4. Weiss NS, Szekely DR, Austin DF. Increasing incidence of endometrial cancer in the United States. N Engl J Med 294:1259-1262, 1976
5. Cramer DW, Cutler SJ, Christine B. Trends in the incidence of endometrial cancer in the United States. Gynecol Oncol 2:130-143, 1974
6. Duncan ID. Stage I endometrial carcinoma in the Tayside region Scotland. In Brush MG, King RJB, Taylor RW (eds): Endometrial cancer; Bailliere Tindall, London, pp. 149-157, 1978
7. Hendrickson MR, Kempson RL (eds). The differential diagnosis of endometrial adenocarcinoma. Some viewpoints concerning a common diagnostic problem. Pathology 12:35-61, 1980
8. Reagan JW, Fu YS. Pathology of endometrial carcinoma. In Coppleson M (ed): Gynecologic oncology. Fundamental principles and clinical practice. Vol. 2. Churchill Livingstone, Edinburgh, pp. 546-561, 1981
9. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, Kolonel LN. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 57:5077-5085, 1997
10. Littman AJ, Beresford SA, White E. The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control 12:691-702, 2001
11. Jain MG, Rohan TE, Howe GR, Miller AB. A cohort study of nutritional factors and endometrial cancer. Eur J Epidemiol 16:899-905, 2000
12. Bosetti C, Altieri A, La Vecchia C. Diet and environmental carcinogenesis in breast/gynecological cancers. Curr Opin Obstet Gynecol 14:13-18, 2002
13. Bokhman JV. Two pathogenetic types of endometial carcinoma. Gynecol Oncol 15:10-17, 1983
14. Beckner ME, Mori I, Silverberg SG. Endometrial carcinoma: Nontumor factors in prognosis. Int J Gynecol Pathol 4:131-145, 1985
15. Burton JL, Wells M. Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium. Histopathology 33:297-303, 1998
16. Deligdisch L, Cohen CJ. Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 56:1452-1455, 1985
17. Deligdisch L, Holinka CF. Endometrial carcinoma: Two diseases? Cancer Detect Prev 10:237-246, 1987
18. Kurman RJ, Zaino RJ, Norris HJ. Endometrial carcinoma. In Kurman RJ (ed). Blaustein's pathology of the female genital tract. 4th ed. Springer-Verlag, New York, pp. 439-486, 1994
19. Kaku T, Tsukamoto N, Hachisuga T, Tsuruchi N, Sakai K, Hirakawa T, Amada S, Saito T, Kamura T, Nakano H. Endometrial carcinoma associated with hyperplasia. Gynecol Oncol 60:22-25, 1996
20. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis. Hum Pathol 26:1268-1274, 1995
21. Ohkawara S, Jobo T, Sato R, Kuramoto H. Comparison of endometrial carcinoma with and without endometrial hyperplasia. Eur J Gynaecol Oncol 21:573-577, 2000
22. Sivridis E, Fox H, Buckley CH. Endometrial carcinoma: Two or three entities? Int J Gynecol Cancer 8:183-188, 1998
23. Sivridis E, Giatromanolaki A. Prognostic aspects on endometrial hyperplasia and neoplasia. Virchows Archiv 439:118-126, 2001
24. Buckley CH, Fox H (eds): Biopsy pathology of the endometrium. 2nd ed. Arnold, London, 2002
25. Hendrickson MR, Ross JC, Eifel PJ, Martinez R, Kempson RL. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6:93-108, 1982
26. Abeler VM, Kjorstad KE. Clear cell carcinoma of the endometrium: A histological and clinical study of 97 cases. Gynecol Oncol 40:207-217, 1991
27. Carcangiu ML, Chambers JT. Early pathologic state clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: Comparison of clinicopathologic features and survival. Int J Gynecol Pathol 14:30-38, 1995
28. Demopoulos RI, Genega E, Vamvakas E, Carlson E, Mittal K. Papillary carcinoma of the endometrium: Morphometric predictors of survival. Int J Gynecol Pathol 15:110-118, 1996
29. Abeler VM, Vergote IB, Kjorstad KE, Trope CG. Clear cell carcinoma of the endometrium: Prognosis and metastatic pattern. Cancer 78:1740-1747, 1996
30. Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, Hoskins WJ, Barakat RR. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO 3 cancer? Int J Radiat Oncol Biol Phys 54:79-85, 2002
31. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, Blessing JA. Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825-832, 1984
32. Abeler VM, Kjorstad KE. Endometrial adenocarcinoma in Norway: A study of a total population. Cancer 67:3093-3103, 1991
33. Sivridis E, Buckley CH, Fox H. The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. Br J Obstet Gynaecol 94:991-994, 1987
34. Announcements. FIGO stages - 1988 revision. Gynecol Oncol 35:125-127, 1989
35. Zaino R, Kurman RJ, Diana K, Morrow C. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. Cancer 75:81-86, 1995
36. Taylor RR, Zeller J, Libermann RW, O'Connor DM. An analysis of two versus three grades for endometrial carcinoma. Gynecol Oncol 74:3-6, 1999
37. Lax SF, Kurman RJ, Pizer ES, Wu L, Ronnett BM. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 24:1201-1208, 2000
38. Ayhan A, Taskiran C, Yuce K, Kucukali T. The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma. Int J Gynecol Pathol 22:71-74, 2003
39. Gusberg SB, Hall RE. Precursors of corpus cancer. III. The appearance of cancer of the endometrium in estrogenically conditioned patients. Obstet Gynecol 17:397-412, 1961
40. Gusberg SB. The changing nature of endometrial cancer. N Engl J Med 302:709-732, 1980
41. Lax SF, Kurman RJ. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol 81:228-232, 1997
42. Lax SF. Dualistic model of molecular pathogenesis in endometrial carcinoma. Zentralbl Gynakol 124:10-16, 2002
43. Sivridis E, Giatromanolaki A. Proliferative activity in postmenopausal endometrium - the lurking potential for giving rise to an endometrial adenocarcinoma. J Clin Pathol: in press, 2004
44. Archer DF, McIntyre-Seltman K, Wilborn WW, Dowling EA, Cone F, Creasy GW, Kafrissen ME. Endometrial morphology in asymptomatic post-menopausal women. Am J Obstet Gynecol 165:317-322, 1991
45. Korhonem MO, Symons JP, Hyde BM, Rowan JP, Wilborn WH. Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2,964 perimenopausal and post-menopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). Am J Obstet Gynecol 176:377-380, 1997
46. Siiteri PK, Macdonald PC. Role of extraglandular estrogen in human endocrinology. In Greep RO, Astwood EB (eds). Handbook of physiology; Section 7, endocrinology. Vol. II, Part 1. American Physiological Society, Washington DC, pp. 615-629, 1973
47. Sasano H, Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev 19:593-607, 1998
48. Cleland WH, Mendelson CR, Simpson ER. Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab 60:174-177, 1985
49. Aiman J. Age, estrogen, and the endometrium. Clin Obstet Gynecol 24:193-202, 1981
50. Siiteri PK, Schwarz BE, MacDonald PC. Estrogen receptors and estrone hypothesis in relation to endometrial and breast cancer. Gynecol Oncol 2:228-238, 1974
51. Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, Skoog L, Somell A, Theve T, Wilking N. Adjuvant Tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1:117-120, 1989
52. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11:485-490, 1993
53. Carcangiu ML. Uterine pathology in tamoxifen-treated patients with breast cancer. Anat Pathol 2:53-70, 1997
54. Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC). Int J Cancer 76:325-330, 1998
55. Sivridis E. Prognostic factors in primary endometrial carcinoma. In Heine H, Rimpler M (eds): Extracellular matrix and groundregulation system in health and disease, Gustav Fischer Verlag, Stuttgart, pp.123-138, 1997
56. Caduff RF, Svoboda-Newman SM, Bartos RE, Ferguson AW, Frank TS. Comparative analysis of histologic homologues of endometrial and ovarian carcinoma. Am J Surg Pathol 22:319-326, 1998
57. Hornreich G, Beller U, Lavie O, Renbaum P, Cohen Y, Levy-Lahad E. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature. Gynecol Oncol 75:300-304, 1999
58. Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, Satagopan J, Offit K, Boyd J. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol 80:395-398, 2001
59. Parc YR, Halling KC, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN, Halling AC. Microsatellite instability and hMLH1/hMLH2 expression in young endometrial carcinoma patients: Associations with family history and histopathology. Int J Cancer 86:60-66, 2000
60. Boks DE, Trujillo AP, Voogd AC, Morreau H, Kenter GG, Vasen HF. Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int J Cancer 102:198-200, 2002
61. Kuismanen SA, Moisio AL, Schweizer P, Truninger K, Salovaara R, Arola J, Butzow R, Jiricny J, Nystrom-Lahti M, Peltomaki P. Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. Am J Pathol 160:1953-1958, 2002
62. Dove-Edwin I, Boks D, Golf S, Kenter GG, Carpenter R, Vasen HF, Thomas HJ. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 94:708-1712, 2002